Literature DB >> 12915565

Pre-s1 antigen-dependent infection of Tupaia hepatocyte cultures with human hepatitis B virus.

Dieter Glebe1, Mehriar Aliakbari, Peter Krass, Eva V Knoop, Klaus P Valerius, Wolfram H Gerlich.   

Abstract

The susceptibility of the tree shrew Tupaia belangeri to human hepatitis B virus (HBV) has been demonstrated both in vivo and in vitro. In this study, we show that purified HBV infects primary T. belangeri hepatocyte cultures in a very specific manner, as detected by HBV covalently closed circular DNA, mRNA, HBV e antigen, and HBsAg production. A monoclonal antibody (MAb), MA18/7, directed against the pre-S1 domain of the large HBs protein, which has been shown to neutralize infectivity of HBV for primary human hepatocytes, also blocked infection of primary Tupaia hepatocytes. MAbs against the pre-S2 domain of HBs inhibited infection only partially, whereas an S MAb and polyvalent anti-HBs antibodies neutralized infection completely. Thus, both pre-S1 and S antigens are necessary for infection in the tupaia. Using subviral particles, >70% of primary Tupaia hepatocytes are capable of specific binding of pre-S1-rich HBsAg, showing localization in distinct membrane areas. The data show that the early steps of HBV infection in Tupaia hepatocyte cultures are comparable to those in the human system.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12915565      PMCID: PMC187384          DOI: 10.1128/jvi.77.17.9511-9521.2003

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  49 in total

1.  Rapid seroprotection against hepatitis B following the first dose of a Pre-S1/Pre-S2/S vaccine.

Authors:  M Y Shapira; E Zeira; R Adler; D Shouval
Journal:  J Hepatol       Date:  2001-01       Impact factor: 25.083

2.  Adult hepatitis B vaccination using a novel triple antigen recombinant vaccine.

Authors:  M D Young; D L Schneider; A J Zuckerman; W Du; B Dickson; W C Maddrey
Journal:  Hepatology       Date:  2001-08       Impact factor: 17.425

3.  Standardized detection of hepatitis B surface antigen: determination of its serum concentration in weight units per volume.

Authors:  W Gerlich; R Thomssen
Journal:  Dev Biol Stand       Date:  1975

4.  Selective extraction of polyoma DNA from infected mouse cell cultures.

Authors:  B Hirt
Journal:  J Mol Biol       Date:  1967-06-14       Impact factor: 5.469

5.  Molecular approaches to validate disinfectants against human hepatitis B virus.

Authors:  C A Jursch; W H Gerlich; D Glebe; S Schaefer; O Marie; O Thraenhart
Journal:  Med Microbiol Immunol       Date:  2002-03       Impact factor: 3.402

6.  Large surface proteins of hepatitis B virus containing the pre-s sequence.

Authors:  K H Heermann; U Goldmann; W Schwartz; T Seyffarth; H Baumgarten; W H Gerlich
Journal:  J Virol       Date:  1984-11       Impact factor: 5.103

7.  Enzymatic amplification of hepatitis B virus DNA in serum compared with infectivity testing in chimpanzees.

Authors:  P P Ulrich; R A Bhat; B Seto; D Mack; J Sninsky; G N Vyas
Journal:  J Infect Dis       Date:  1989-07       Impact factor: 5.226

8.  Antibodies to synthetic peptides from the preS1 region of the hepatitis B virus (HBV) envelope (env) protein are virus-neutralizing and protective.

Authors:  A R Neurath; B Seto; N Strick
Journal:  Vaccine       Date:  1989-06       Impact factor: 3.641

9.  A virus in Beechey ground squirrels that is related to hepatitis B virus of humans.

Authors:  P L Marion; L S Oshiro; D C Regnery; G H Scullard; W S Robinson
Journal:  Proc Natl Acad Sci U S A       Date:  1980-05       Impact factor: 11.205

10.  Presence of receptors for polymerized albumin in HBsAg-containing hepatocytes and hepatoma cell line.

Authors:  S N Thung; M A Gerber
Journal:  Hepatology       Date:  1981 Mar-Apr       Impact factor: 17.425

View more
  69 in total

1.  Humanized murine model for HBV and HCV using human induced pluripotent stem cells.

Authors:  Xiao-Ling Zhou; Gareth J Sullivan; Pingnan Sun; In-Hyun Park
Journal:  Arch Pharm Res       Date:  2012-02-28       Impact factor: 4.946

2.  A hepatitis B virus causes chronic infections in equids worldwide.

Authors:  Andrea Rasche; Felix Lehmann; Nora Goldmann; Michael Nagel; Andres Moreira-Soto; Daniel Nobach; Ianei de Oliveira Carneiro; Nikolaus Osterrieder; Alex D Greenwood; Eike Steinmann; Alexander N Lukashev; Gerhard Schuler; Dieter Glebe; Jan Felix Drexler
Journal:  Proc Natl Acad Sci U S A       Date:  2021-03-30       Impact factor: 11.205

3.  Identification of a structural motif crucial for infectivity of hepatitis B viruses.

Authors:  Lars Stoeckl; Anneke Funk; Ariane Kopitzki; Boerries Brandenburg; Stefanie Oess; Hans Will; Hüseyin Sirma; Eberhard Hildt
Journal:  Proc Natl Acad Sci U S A       Date:  2006-04-17       Impact factor: 11.205

4.  Assembly of hepatitis delta virus: particle characterization, including the ability to infect primary human hepatocytes.

Authors:  Severin Gudima; Yiping He; Anja Meier; Jinhong Chang; Rongji Chen; Michal Jarnik; Emmanuelle Nicolas; Volker Bruss; John Taylor
Journal:  J Virol       Date:  2007-01-17       Impact factor: 5.103

Review 5.  Viral and cellular determinants involved in hepadnaviral entry.

Authors:  Dieter Glebe; Stephan Urban
Journal:  World J Gastroenterol       Date:  2007-01-07       Impact factor: 5.742

6.  Two potentially important elements of the hepatitis B virus large envelope protein are dispensable for the infectivity of hepatitis delta virus.

Authors:  Severin Gudima; Anja Meier; Roland Dunbrack; John Taylor; Volker Bruss
Journal:  J Virol       Date:  2007-01-24       Impact factor: 5.103

7.  Bats carry pathogenic hepadnaviruses antigenically related to hepatitis B virus and capable of infecting human hepatocytes.

Authors:  Jan Felix Drexler; Andreas Geipel; Alexander König; Victor M Corman; Debby van Riel; Lonneke M Leijten; Corinna M Bremer; Andrea Rasche; Veronika M Cottontail; Gael D Maganga; Mathias Schlegel; Marcel A Müller; Alexander Adam; Stefan M Klose; Aroldo José Borges Carneiro; Andreas Stöcker; Carlos Roberto Franke; Florian Gloza-Rausch; Joachim Geyer; Augustina Annan; Yaw Adu-Sarkodie; Samuel Oppong; Tabea Binger; Peter Vallo; Marco Tschapka; Rainer G Ulrich; Wolfram H Gerlich; Eric Leroy; Thijs Kuiken; Dieter Glebe; Christian Drosten
Journal:  Proc Natl Acad Sci U S A       Date:  2013-09-16       Impact factor: 11.205

8.  Fine mapping of pre-S sequence requirements for hepatitis B virus large envelope protein-mediated receptor interaction.

Authors:  Andreas Schulze; Alexa Schieck; Yi Ni; Walter Mier; Stephan Urban
Journal:  J Virol       Date:  2009-12-09       Impact factor: 5.103

Review 9.  Is hepatitis B-virucidal validation of biocides possible with the use of surrogates?

Authors:  Andreas Sauerbrei
Journal:  World J Gastroenterol       Date:  2014-01-14       Impact factor: 5.742

10.  Molecular determinants of hepatitis B and D virus entry restriction in mouse sodium taurocholate cotransporting polypeptide.

Authors:  Huan Yan; Bo Peng; Wenhui He; Guocai Zhong; Yonghe Qi; Bijie Ren; Zhenchao Gao; Zhiyi Jing; Mei Song; Guangwei Xu; Jianhua Sui; Wenhui Li
Journal:  J Virol       Date:  2013-05-15       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.